average a1c reduction glp-1 treatment Eli Lilly's oral for type 2 diabetes submission in the U.S GLP-1s Lead to Greater Weight

N., Sun, L., Rahman, M

The Morning Protein Advantage Before we dive into specific breakfast ideas, you need to understand why morning protein matters so much when you're taking GLP-1 medications

Semaglutide is a synthetic GLP-1 receptor agonist

For the treatment-regimen estimand, the mean body weight reductions from baseline at 72 weeks were 15.0%, 19.5%, and 20.9% in the tirzepatide 5, 10, and 15 mg groups, respectively, versus 3.1% in the placebo group

Discuss with your provider whether the additional weight loss justifies the higher dose, or whether maintaining at the plateau weight with the current dose is the more appropriate goal